stella
beta
Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02) — Stella
Recruiting
Back to Esophageal Squamous Cell Carcinoma (ESCC) trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
Shanghai Zhongshan Hospital, Shanghai, Shanghai Municipality
View full record on ClinicalTrials.gov